002737SZSE
🚨 Material Event

Announcement on Resolutions of the 23rd Meeting of the 5th Board of Directors

✨ AI Summary

The company held its 23rd Board meeting via communication, approving the transfer of fund shares for RMB 1 million and the divestment of equity in Beijing Famar Xing Pharmaceutical Technology Co., Ltd. for RMB 34.285768 million. It also approved the establishment of a wholly-owned subsidiary and the appointment of a Deputy General Manager.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Sunflower Pharmaceutical Group Co., Ltd.

Announcement on Resolutions of the 23rd Meeting of the 5th Board of Directors

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and there are no false records, misleading statements, or major omissions.

I. Convening of the Board Meeting

The 23rd Meeting of the 5th Board of Directors of Sunflower Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company" or "this Company") was convened via communication on July 24, 2026, at 9:00 AM. The meeting was convened by Ms. Guan Yuxiu, the Chairman of the Company. The meeting notice and proposals were sent via email on July 20, 2026. A total of 9 directors were eligible to vote, and 9 directors actually participated in the voting. The convening and procedures of this meeting comply with the "Company Law," relevant laws and regulations, and the "Articles of Association." The resolutions of the meeting are legal and valid.

II. Deliberation of the Board Meeting

1. Approval of the "Proposal on Transferring Fund Shares and Exiting Hangzhou Xiaochi Fund"

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.